exit_to_appLogin
forum

VENUSREM Share Price Discussion

Venus Remedies Ltd.
Sector: Pharmaceuticals and health care
... Read more
VENUSREM Share Price *
23.1 -0.35 (-1.49%)
* (quote may be delayed)

VENUSREM Discussion Forum

NewsBot @newsbot
 in 
VENUSREM
•
Feb 18 4:57 PM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
VENUSREM
•
Nov 16 4:17 PM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
VENUSREM
•
Nov 15 5:52 PM
Like
reply
Reply
share
Share

  • VENUSREM - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization40.91
    Enterprise Value379.37
    Price to Earnings25.4
    Price to Book Value0.12
    Return on Capital Employed0.02
    Return on Equity-0.07
    Face Value10
    Dividend YieldNA

  • VENUSREM Share Price - Technicals

    keyboard_arrow_down
    VENUSREM - 52 Week High₹68
    VENUSREM - 52 Week Low₹18.8

  • VENUSREM Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 182323.92323.25
    Sep 1723.323.92323.45
    Sep 1624.3524.3522.623.15
    Sep 1324.124.423.824.25
    Sep 1223.2524.7523.2524.1

  • VENUSREM Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹23.05
    30 Day Moving Average₹23.52
    50 Day Moving Average₹23.32
    100 Day Moving Average₹25.84
    200 Day Moving Average₹32.24

  • VENUSREM - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue355375.45-0.05
    Operating Profit4375.04-0.43
    Profit Before Tax-231.05-22.9
    Net Income-274.75-6.68

  • VENUSREM - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds341368-0.07
    Total Liabilities3913800.03
    Total Assets732749-0.02

  • VENUSREM - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity52102.56-0.49
    Cash from Investing Activity-11-45.87-0.76
    Cash from Financing Activity-40-56.58-0.29
    Net Cash FlowNA0.11-1

  • VENUSREM - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets-0.040.01
    Return on Equity-0.070.01
    Return on Capital Employed0.020.05

  • VENUSREM - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.21
    3 Year CAGR Growth in Operating Profit-0.51
    3 Year CAGR Growth in EBIDTA-0.5
    3 Year CAGR Growth in Net Income-6.93
    3 Yr CAGR Growth - Diluted EPS-6.48

  • VENUSREM - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.23
    5 Year CAGR Growth in Operating Profit-0.64
    5 Year CAGR Growth in EBIDTA-0.63
    5 Year CAGR Growth in Net Income-1.47
    3 Yr CAGR Growth - Diluted EPS-1.4

  • VENUSREM Share Price - Recent News

    keyboard_arrow_down

  • VENUSREM - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.
HelpAboutPrivacyTermsDisclaimersRefunds